 Eloxx Pharmaceuticals OTCMKTS:ELOX had its target price decreased by Citigroup from 31.00 to 11.00 in a research note issued to investors on Monday, The Fly reports. The firm currently has a neutral rating on the stock. Citigroups price target indicates a potential upside of 245.91 from the stocks previous close. A number of other research ... 